Good morning and welcome to Dover's First Quarter 2021 Earnings Conference Call. Speakers today are Richard J. Tobin, President and Chief Executive Officer; Brad Cerepak, Senior Vice President and Chief Financial Officer; and Andrey Galiuk, Vice President of Corporate Development and Investor Relations. [Operator Instructions]. As a reminder, ladies and gentlemen, this conference call is being recorded and your participation implies consent to our recording of this call. If you do not agree with these terms, please disconnect at this time. Thank you. I would now like to turn the call over to Mr. Andrey Galiuk. Please go ahead, sir.

Thank you, Laurie. Good morning, everyone, and thank you for joining our call. This call will be available for playback through May 4 and the audio portion of this call will be archived on our website for three months. Dover provides non-GAAP information and reconciliations between GAAP and adjusted measures are included in our investor supplement and presentation materials, which are available on our website. We want to remind everyone that our comments today may contain forward-looking statements that are subject to uncertainties and risks, including the impact of COVID-19 on the global economy and our customers, suppliers, employees, operations, business, liquidity and cash flow. We caution everyone to be guided in their analysis of Dover by referring to our Form 10-K and Form 10-Q for the first quarter for a list of factors that could cause our results to differ from those anticipated in any forward-looking statement. We undertake no obligation to publicly update or revise any forward-looking statements, except as required by law. With that, I will turn this call over to Rich.

Thank you, Andrey. Good morning, everyone. We have a big group this morning. So we're going to have a robust Q&A session. So, let's move to page three. The business challenge moving into Q1 was twofold for Dover. First, we exited 2020 with a healthy backlog of business which we needed to operationally deliver against. Back end, we had to work closely with our distributors and customers to seize opportunities in the marketplace despite a complex set of challenges with raw materials, components, logistics and labor availability. We are pleased with our first quarter performance on both counts, which is reflected in our robust revenue growth and the increase in our order backlog as we move into Q2. Let's take a look at the metrics. Total revenue is up 13%, 9% organic to the comparable period. Clearly, the quarter benefited from a good order, backlog position and the willingness of the channels to receive product deliveries as market demand accelerated, resulting in the highest volume quarter since 2014 and the largest first quarter volume since 2012 for the company. This performance is a clear indication that our product portfolio is attractive and often underappreciated growth avenues and that the work that we have done on operational excellence is gaining traction. Order rates outpaced revenue in the quarter, posting bookings of $2.3 billion, a 27% comparable organic increase. The growth was broad based with all five segments contributing to the increase. This resulted in the seasonally high backlog of $2.2 billion, an increase of 39%. Since our earnings are issued among the first in the industrial sector, I suppose it's on us to explain the drivers of growth and their impact on seasonality and full-year demand. I'm going to try to be careful with my choice of terms and comments not…

Thanks, Rich. Good morning, everyone. I'm on slide 6. On the top is the revenue bridge. Our top line benefited from organic growth across all five segments, with particular strength in Pumps & Process Solutions and Refrigeration & Food Equipment segments. FX benefited top line by 3% or $51 million. Acquisitions more than offset dispositions in the quarter by $15 million. We expect this number to grow in subsequent quarters. The revenue breakdown by geography reflects strong growth in North America, Europe and Asia, our three largest geographic regions. The US, our largest market, posted 7% organic growth in the quarter on solid order rates and retail fueling, marking, coating, biopharma connectors, food retail and can making among others, and was partially offset by delayed shipments and waste hauling. Europe grew by 13% in the quarter on strong shipments and vehicle aftermarket, biopharma, industrial pumps and heat exchangers. All of Asia returned to growth and was up 20% organically, driven by China, which was up 60% against the COVID impacted comparable quarter in the prior year. Moving to the bottom of the page. Bookings were up 27% organically, reflecting the continued broad-based momentum we are seeing across the portfolio. In the quarter, we saw organic bookings growth across all five segments. Overall, our backlog is currently up $626 million or 39% versus this time last year, positioning us well for the remainder of the year. Let's go to the earnings bridges on slide 7. On the top of the chart, adjusted segment. EBIT was up nearly $100 million and margin improved several 100 basis points as improved volumes, continued productivity initiatives and strategic pricing offset input cost inflation. Going through the bottom of the chart. Adjusted net earnings improved by $60 million as higher segment EBIT more than offset higher taxes, as well as higher corporate expenses, primarily related to compensation accruals and deal expenses. The effective tax rate excluding discrete tax benefits was approximately 21.7% for the quarter compared to 21.5% in the prior year. Discrete tax benefits were $6 million in the quarter or approximately $3 million lower than in 2020. Right-sizing and other costs were $4 million in the quarter or $3 million after tax. Now on slide 8. We were pleased with the cash flow performance in the first quarter with free cash flow of $146 million or $110 million increase over last year. Free cash flow conversion stands at 8% of revenue in the first quarter, which is historically our lowest cash flow quarter due to seasonality of our production. Let me turn it back to Rich.

Thanks, Brad. Let's go to slide [technical difficulty]. We expect demand in Engineered Products to improve sequentially through the remainder of the year, which is supported by a robust backlog. We continue to see strong bookings trends in vehicle services and industrial automation. Aerospace and defense have significant revenue visibility through its government programs and is booked well into the second half of the year. Order rates on waste handling improved significantly during the first quarter, though the shipment schedule will be levered towards the second half and we're watching the supply chain here closely, which is a stabilizer we expect a gradual recovery through the second half of the year. As communicated on our investor meeting in November, we expect Fueling Solutions to post moderate organic growth for the year. There was a known headwind from EMB roll off in the US, but order trends support a number of positives offsetting it, including growth in systems and software, recovery in underground businesses and growth in vehicle wash. We also expect that Asia, China in particular, should stabilize and become a net positive for us in the second half. The ICS acquisition which we closed at the end of last year is off to a very good start as vehicle wash market is recovering healthily. Imaging & ID is expected to perform well this year. Our core marking and coating business, stalwarts in 2020, is expected to continue to deliver low to mid-single digit growth with services and serialization products positively impacting performance. Digital textile printing remains slow, although we saw a year-over-year improvement in ink tonnage sales in Q1 as we continue executing our strategy to attach consumables to machine sales. We expect recovery here in the second half. Pumps & Process Solutions should have another solid year. Demand…

[Operator Instructions]. Our first question comes from the line of Steve Tusa of J.P. Morgan.

Rich, this is the most excited I've heard you in a while. Way to jump out of your shoes there. The kind of rest of the year guidance, I just wanted to kind of get an idea of – you mentioned there, these kind of like – I think they were bookings tailwinds this quarter, but not necessarily revenue tailwinds. But when I look at kind of the rest of the year and I just kind of simply divide the rest of the year guide to quarterly just to get to a quarterly number, and keeping in mind the first quarter is usually like a pretty low number seasonally, it seems like sequentially to the rest of the year quarterly that you have EPS, EBIT kind of softening and actually down sequentially and sales basically kind of flattish for the rest of the year just on a quarterly – kind of simple quarterly divided by three, rest of the year divided by three. So, is there something like a fundamental that will drop off other than EMB? You'd mentioned a lot of these businesses have a second half that actually looks pretty good. Anything we're missing on this one?

No. Look, at the end of the day, Q1 was stronger than we expected. So, I think that we're quite pleased in our ability to pivot operationally to get the product out the door. I think that we're probably being arguably conservative to get another quarter under our belt to see how much of that backlog and demand is being influenced by channel restocking and trying to get in front of raw material perceived price increases in the future. And I'm not entirely clear right now how much of Q1 overperformance was taken from Q2, which is seasonally when we kind of ramp. So, it's usually a low Q1, big move in Q2, Q3 and then kind of run for cash in Q4. You just can't do the math and say, well, historically, it's been this percentage of revenue and operating profit and this is what the seasonality is, and if I take Q1 as a proxy and I run my spreadsheet, it kicks out an extraordinarily high number, both on the revenue side and the operating margin side. So, from the revenue side, I think fair enough, we may be a little conservative. We'd like to see our bookings go through Q2. I'll tell you sitting here in April that it's not deteriorating, which is a good news. So, that portends a pretty decent Q3 that we've got coming up, but we'd like to see how that develops over time. Because make no mistake, there's a couple of things here. Operationally, it is getting kind of difficult out there in terms of sourcing raw materials, labor availability, a variety of different things out there. We had some headwinds in the first quarter, but I'll tell you that operationally, we plowed through. We're not out of the woods yet. Right…

One last question. Q2 EPS, will they actually grow sequentially?

Yeah. Yeah, yeah. Without question.

Your next question comes from the line of Andy Kaplowitz of Citigroup.

Rich, maybe following up on margin. You've been asked before about achieving a 20% adjusted segment operating margin many times. You did just record over 19%. Obviously, a strong quarter there. And we know one quarter doesn't dictate a trend. But is 20% as a long-term target, maybe too low at this point, given how well you're operating in the businesses?

Well, I didn't expect that one today, Andy. Look, I'll put it this way. We're pleased with the operational performance and we're pleased with the mix impact on the operating margin, clearly reaching 19% at the segment level in Q1 of 2021. The 20%, I guess, is earlier in reach than even we had been modeling it in the past. Now, that is going to be – I'm not going to do this big mix discussion again. I guess over the balance of the year – so number one, the answer is we're going to get to 20% earlier than we thought based on current trajectory. So, what that means – I'm not putting a target out there yet. We'll give you one maybe in Q3. What we are going to fight against between now and the end of the year, we've discussed the mix impact of margins, is inflationary input costs between raw materials, labor, and price costs. As we discussed, at the end of 2020, we were on the front foot in terms of getting price out there. Think about it in terms of inventory change, the inflation on the raw materials was not in our inventory. So, you get positive price cost early in the transition as long as you stay on the front foot. Now, we're going to be really closely watching price cost over the balance of the year in terms of net realization. So, we would have expected to get the biggest benefit in Q1. By and large, that's where we expect it. The way it's looking, we may have to intervene on price, again, in certain of the businesses over the balance of the year. And that will impact the margin performance. So, yeah, look, 2020 when we put the target out there was 400 basis points improvement, I think, from the time period we put it out there. Clearly, I think we'll be revisiting those longer-term targets sometime this year.

Just following up on he sort of the confidence level in DRFE in the sense that you've got now a couple quarters of revenue and backlog. I did notice you talked about increasing capacity at Belvac in heat exchangers. So, you've said before, Rich, that it could be a multi-year cycle in this business. Does the confidence level go up around that sort of comment in the past? Do you see potential for double-digit growth, mid-teens margins? Is the confidence level around that higher now?

Well, it's getting higher with every passing month of the backlog build. So if you go back and look at the comments, refrigeration gets a lot of the color, it's the biggest piece of the segment, their backlog continued to build. That's the one that we said that we're relatively confident that we're in kind of a secular growth period for, we would say, 36 months [indiscernible] see it. I think it's been augmented now by transition to CO2 which should be somewhat of a tailwind that we didn't really recognize maybe even six months ago. So I think that's helpful. And how long the transition from expanding capacity in can making and the transition from PEP to aluminum, how long that goes, remains to be seen. As Brad mentioned I think in his comments, we're booking well into 2022 now. On the heat exchanger side, I think that we are outgrowing the market quite frankly. I think that we've got some unique positioning, especially in heat pumps. We are expanding capacity now. So, based on new product launches and expanded capacity, I think that we can outgrow the market. But generally speaking, that's a low-single digit growing market over time. We'd like to see if we can push through and kind of outperform.

Your next question comes from one of Jeff Sprague of Vertical Research.

On the supply chain stuff, it doesn't sound like it's the stuff that's front and center in everybody's mind, i.e. semiconductors. It sounds like it might be kind of more basic sort of stuff. Could you actually elaborate a little bit on the on the types of pressures you're seeing and how widespread they are?

I think we have some exposure on electronic components. It's not huge, but it does impact a few of our businesses. And that is more not chip bait. That is logistics supply chain based. So, you can go take a look at what's going on in the Port of Los Angeles right now. I'm hoping that that will unbuckle now that COVID seems to be passing. But a lot of that is just moving the materials that are sourced out of Asia. But the whole freight logistics chain is kind of – I guess it's tight right now. And it's tight. And it's reflected in the logistics costs that we've had to bear. And it's tight in terms of getting the deliveries we want. But then, like anything else at Dover, becomes very anecdotal because we're not vertically integrated industrial, making one product. So, we've had issues with hydraulic components in ESG. We'd have issue with lighting systems in refrigeration. So, there's a laundry list of things. But for the most part, it's, let's call it, supply chain logistics constraints that are impacting us.

Pump & Process margins did look, I guess I could say, awesome. I would assume there's an unusually rich mix in the quarter. But maybe you could just provide a little bit of color on what you think kind of normalized margin rates are in that business?

It is a very good mix in the quarter. We made that presentation last year about our biopharma and single use pumps business. I kind of tried to give everybody idea what that business was capable of delivering at. So, that was a business because of its capacity utilization is running – is converting at gross margin level right now, which is very healthy. We're watching it closely. Right now, it is actually a short cycle business. We're trying to build our backlog, but we really don't have a lot of visibility. So I think that we're being prudent in terms of our second half estimates, in terms of how long that goes. On the industrial pump side, it's actually been quite robust also, but that's more channel inventory. Interestingly, we had a very good performance in China in the pump business in Q1, and it's been some time since we've seen that, and the margins were quite healthy. And you have to recall that the management had been very proactive in taking costs out in 2020. And so, we have the roll forward benefit on the industrial pump side on the margin moving into 2021. So, that was quite healthy. I think on pumps and polymers, this is a business that I think that the management team has effectively doubled the margin in the last three years. So, gross margins in that business are healthy again. So, overall, what's going to impact the margin the most is going to be mix. Even when precision components does come back in the second half, it's not overtly dilutive to it. Slightly so. The bigger issue is going to be how does demand hold up on single use pumps in the second half of the year?

Your next question comes from the line of Julian Mitchell of Barclays.

Maybe just a first question around just the organic sales outlook. So, heard you loud and clear on the RFP getting better as you go through the year. I just wondered if you could revisit perhaps the organic growth outlook by segment. You gave numbers on the Q4 call for each one. Just wondered in the context of your higher organic growth guide, it looks like about two points maybe firm-wide, which were the divisions that really led that organic growth increase for the company overall?

Let's start at the top. If our capital goods businesses return in the second half, as we would expect, that would meet our original forecasts, I think it's – vehicle services group looks to be poised to get a – probably a full point of organic growth that we did not expect at the beginning of the year. The printing and ID business is performing as expected. Clearly, the upside is if textile comes back in a robust fashion in the second half. Right now, we don't have the backlog that would support that thesis. But if it turns, we'll probably have a lot more color on that one at the end of the second quarter. DFS looks like it may have a point, if not two. One of those points is based on the acquisitions that we've made. So, you get a point of growth there. When that rolls into organic or not, I have to look in the calendarization of blah, blah, blah. But just in terms of total, that's why we gave out total growth early on here and didn't try to parse it between organic and inorganic, but we may get a point of growth. We'd like to take a real close look on OPW or the undergrad portion of it and see how it develops on hanging hardware. But we'd expect that to get better over the year, offsetting what's likely to be the negative EMB headwind that we have on the above ground side in the second half. I answered Jeff Sprague's question about Pumps & Process Solutions. So I've gone through that one. And look, our backlog in DRFE, Belvac adding to its backlog doesn't do anything with the revenue. They're going to pause, it's purely execution now, how much of that backlog they can realize. And we just expanded capacity there to help them do it. I think the outlier is going to be refrigeration. So, we've got a real robust backlog. That is a short cycle business. So, we don't have – I think we may be eating into the beginning of Q3 right now in terms of orders. So we don't have anything for Q4. I think we probably need another quarter to kind of get that tightened down.

Definitely, the operating margin, you sound very confident in that 30-percent-ish conversion range off a higher sales number. The free cash flow margin guide is similar to before, higher free cash flow, I suppose in dollars because of the revenue guide increase. The capex guide is unchanged. So, you're just kind of dialing in, maybe – look, it's a very complicated operating environment that may put some extra strain on working capital over next six months. Maybe just help us understand what impacts we see in the cash flow from these constraints on components and so forth? Not so much the P&L.

Okay, a couple of things. We are giving latitude to our businesses to build working capital to compete for market share at this point, number one. And number two, I think that we mentioned, at the end of the year, we've given some latitude on working capital to prebuy their own raw materials to get in front of what we expect it to be inflationary environment. The fact of the matter is, in Q1, the performance is based on a couple things. Number one, we did not – our payables balance exiting 2020 was not as high as it had been in previous quarters. So, there wasn't a snap back in terms of making those payables in Q1 that we've seen in the past. And quite frankly, our conversion or velocity of working capital in Q1, because the revenue was what it was, was a lot higher than we would normally see. So, look, [indiscernible] hit your nail on the head. In absolute terms, if we're guiding the revenue up and the margin looks like it's proactive, then in absolute dollars, then free cash flow should move at the same. We're working really hard on it. And I think that we probably like a quarter or two can revisit the metric as a percent of revenue. But for right now, I think we're confident that absolute dollar cash flow would be quite healthy.

Your next question comes from the line of Andrew Obin of Bank of America.

Just a follow-up question on sustainability of margin in Pumps & Process Solutions? Do you guys have a sense on dynamic between, particularly in biopharma, between the base business, diagnostics, and other COVID related stuff? Just sort of thinking, if you look at life science companies, right, some companies are more exposed to tests. So, those may turn negative next year. But then other companies say, hey, going into 2022, there's enough base year building that it's going to be sort of sustainable growth into 2022. So how should we think about that business?

Well, you basically have the Q&A that we give to the person that runs that business for us, and we try to unpack that. The only recent data that we do have is that development for follow-on vaccines looks like it's quite robust, number one, and that there was a view at some point that you are going to move from skid development to much larger incubators over time and that transition is negative to single use and we don't see it right now. Now, does that change between now and the end of the year? Our view? I'm sure it will change every quarter as we work through it. And that's why we're being a bit cautious in terms of the duration of the demand that we have in that particular sector. Because if it goes to large incubation, then the volume or the demand, this is a business that's been growing in the high teens for 24 months now. When that begins to roll over, right now we don't see it. I can tell you that right now, we're expanding at capacity again in the case that it's durable. But it's hard to say right now.

Just sort of thinking about refrigeration. This sort of, A, what I'm trying to get at sort of thinking about normalized margins for refrigeration. When do you think we will hit normalized volumes? And how should we think about incrementals in refrigeration? You did say it's going to be negative for the mix. But given all the restructuring, could these guys have high incrementals and corporate average for the rest of the year? So, two questions.

I don't know. I'd have to go do the sums for corporate average, but our expectation that they will be a larger contributor to year-over-year profits in at minimum Q2 and Q3.

Your next question comes from the line of John Inch of Gordon Haskett.

Rich, I'm wondering if we could just maybe provide a little bit more context around your strategic pricing, whatever you'd like to offer. So, sort of what businesses – are you raising prices? What businesses do you still have to raise prices for? And what's the channel reception? Is everybody else doing it too? And just any kind of context you could provide us? Is this also going to get worse as they go throughout the year? You think it's going to kind of hold where things are?

Can I say hard to say, John? Look, we're raising prices – this all started with raw materials. So, you can go through our portfolio. Clearly, the capital goods side has got the biggest exposure to the raw materials and they were on the front foot at the beginning. And from what we can see, so far, it looks like the entire complex is following along. Now it takes 90 to 180 days to see what realization is because you get pricing out there, then you got inventory turns, and blah, blah, blah. So, that's where it started. But the fact of the matter is, I get it that the Fed doesn't want to recognize inflation. But there is inflation. And it's not just the raw materials because raw materials are in the sub-components that we buy from our vendors who are trying to pass along the same kind of price increases that goes into our bill of materials and everything else. And clearly, at the assembly level, on labor, availability is becoming a problem. And that is beginning to start to move up labor costs over time. So, it's now gone from – it's the capital good sides that are buying a lot of raw materials. Now it's moving into the assembled components portions of the business, that is going to have to accommodate that over the balance of the year. On top of that, as I mentioned before, logistics costs, we ship a lot of product that's FOB. It's more inbound logistics costs than it is outbound logistics costs. But freight costs are going up because – God forbid you have to air freight anything right now, it's a bit of a negative. So, we are going to be on it in terms of price costs. And it's hard for us because of the disparity of the SKUs that we have in this portfolio. It's not like we're making cars. So we're going to be on it. And it's a trailing number and we're going to have to do it as a combination of as the numbers come out and our intuition going in. But at worst, it's going to have to be a scenario of net neutral.

At worst, okay. Interestingly enough, does this provide a framework or opportunity for Dover if this tentacle of inflation or these tentacles of inflation really kind of proliferate to start to raise prices, perhaps not on so much a surgical basis? So, it's sort of implied in your answers, the channel is not really resisting. People aren't saying, excuse me, you can't raise prices in this regard, we'll go to competitor B or whatever. None of us want to see rampant inflation. But if there's mild inflation that's across the board, can Dover start to raise pricing in other areas that maybe aren't quite as affected, but still help your profitability, particularly if the channel is kind of more willing to accept because of general inflation, blah, blah, blah?

Well, I guess the answer is yes. But let me give you an example. We have raised prices in refrigeration and lost volume because of it. Because we're more interested in that particular business to raising the operating margin. And as a material component of the market structure, it's up to us to lead the market and stop complaining about the fact that there's no pricing power in it. So, that's an example there. We've got certain other businesses where our gross margins are significantly higher. And there, we may waive it off because if we've got an opportunity to grab share, now's the time to do it. So, we don't manage the portfolio and giving a – here's the three bullet points and everybody go execute it. We do it based on market structure, competitive environment, and a variety of other things. So, it's a combination of a variety of things. Whether it's price cost, positive defaults to the bottom line, or market share gains and gross margins that fall to the bottom line, we'll take it either way.

Your next question coming from the line of Scott Davis of Melius Research.

Rich, I don't think you mentioned in your prepared remarks anything about the M&A pipeline. Is there any light at the end of the tunnel with the higher valuations that you're seeing out there or availability of assets?

Well, I guess the good news, Scott, is that as our margins move up, we can be more expansive in terms of what the multiple was willing to pay because if we wound the clock back a couple years ago, a lot of what we looked at was trading at a much higher multiple that we're trading at and we've gone a long way of fixing it. So, yeah, we're looking at some interesting things in the pipeline. Look at the cash flow this year, is proactive. So, as I mentioned at the end of last year that we're going to make some quicker decisions probably this year in terms of capital deployment or capital return. So, yeah, I think that – look, the management team here was challenged to deliver margin accretion over time on the base portfolio. And the trade-off was, if you do so, then we're going to reinvest in your businesses. We've done that on an organic basis in a meaningful way. I think that we've got certain portions of the portfolio that have earned the right now to be a little bit more expansive inorganically. So, we're probably more on the front foot today than we've been in my tenure here.

You'd mentioned, I think, at one of the conferences a couple of new automation projects that you guys are doing, I think, in vehicle and waste. But can you give us a little bit of color on those projects? And any sense of how do you cadence stuff like that into an up cycle when you're trying to manage high demand, but also you might have some downtime and such to implement projects?

Yeah, you've got to be careful. I think that we've done a few of them here now. So I think that we're getting better at them in terms of how much inventory do we have to prebuild to accommodate for execution risk. I'm confident that I think that the two bigger ones that we have going on right now, we've got – just like we did in refrigeration – the floor space to accommodate kind of the CapEx portion of the project, to run on the installed base. So you've got a transitory period, but it's not as if you have to shut down to redo the plant and do it that way. It's kind of you build it on the side and you just open it up over time. A lot of what else we're doing now is we're doing a lot of work on the machining centers. And that's productivity related that we're spending pretty heavily in right now. And that's some of our lower gross margin businesses. We're trying to kind of bring those up over time. And we've got some real interesting ones going on in some of our higher volume throughput businesses on inspection technology that is allowing us to increase capacity without expanding the physical footprint. And that's the one I referenced before on the biopharma side.

Your next question comes from the line of Joe Ritchie of Goldman Sachs.

Rich, we talked a little bit about inventory levels being low and the demand environment remaining robust. So, it's clearly like not a pull forward in demand. I'm just wondering, like, when you think about raw material availability in 1Q and some of the supply chain disruption that you saw, was there a certain amount of revenues that you couldn't book in 1Q that got pushed out into 2Q? Maybe some color around that would be helpful.

No, overall, as a corporation, we overdeliver. I would have expected that we could have forced through the funnel. If I told you about the meetings we were having around here in early January about our Q1 forecasts, we were yelling at everybody about moving them up. And then we've got a lot of demand. And I would have expected that we would have had – we had anecdotal issues that I referenced, but the fact of the matter is, in total, we over delivered. So, what went on in Pumps & Process Solutions as a whole, their ability to get that amount of product out in an intra-quarter period where they actually didn't even have all those orders, I think, was impressive. So, we did lose some volume in ESG. We lost some volume in refrigeration. But overall, we over deliver them what I would have expected if I looked at kind of backlog conversion expectation going into the year.

I guess maybe just kind of following on that conversation with John on price cost. It looks like you've got about 80 basis points of price this quarter. You made some comments around – not all the costs are inflationary costs that would be in your inventory. So, I'm just curious to see whether it's discussing the price cost impact in 1Q or how you see that playing out for the rest of the year. I'm just curious to hear how you're thinking this is going to – the trajectory is going to look like going forward?

I think that we would have expected to be positive in Q1 just because of the timing of the action that we took on pricing, which actually started in Q4 of last year. And then it gives then between what's stuck in inventory and then what is pre-announced kind of these – the price increases effective April 1 and how does that drive backlog and whether you can reprice that backlog. I think that we're vigilant about it. But bottom line is, the only way we're really going to know is over time. So, I don't know Q2 right now, whether we're going to be price cost, whether it's going to be a credit or debit. I think it's going to be a credit, right? But between announced price increases and price realization, and all of the noise around the subcomponents because you can't measure inflation and you can do it for raw materials and castings because it's kind of bulk orders and you only have a few suppliers, but you're talking about subcomponents across this portfolio, it's quite difficult to measure. So, Brad and I were discussing it this morning. It's the one thing that we've got to really keep our eyes on. And look, we'll have more color on it by the time we close Q2.

Our final question will come from the line of Josh Pokrzywinski of Morgan Stanley.

Just taking a step back on kind of the recovery as a whole here, Rich, you guys are going to be back to pre-COVID levels pretty soon and certainly before year end, it looks like. Where are you seeing evidence that this is maybe a stronger recovery versus the line that you used earlier that you had some pent up demand from 2020? Like, is this a stronger cycle? Or is this sort of catch up on stuff that really should have gotten done last year?

All of the above, Josh, I guess. Look, if we go back to 2019, we've introduced a lot of new products, believe it or not, between our 2019 base and our 2021 trajectory. We've also been, I want to say, overly active in M&A, but we did some inorganic investments from 2019 through 2021. So, those end up being topline credits. Forget what the total aggregate demand environment is. Look, the recovery looks like it's broad based at the end of the day. There are trade-offs were, in 2019, certain geographies are stronger, and now they're weaker, but they have their own reasons why. I think that the only one that we can really point to where there's an inflection of the demand environment is refrigeration. But we talked about that, leading into 2021, where we went through a three to four year period where the capital base was under invested by big box retail and now we're going into a cycle. We're calling it a three year cycle. Let's hope it's four. And then you've got some interesting changes in in – structural changes like that are impacting things like Belvac where this transition to aluminum cans is kind of cyclical where you know that business hasn't grown in a very long time. And now it's making a pretty sweeping transition for COVID reasons and environmental reasons. So, the 2019 base is important, but we would have expected that if we rebased 2019 for new product launches and acquisitions, that base would have been higher anyway at the end of the day, if that answers your question.

We've sort of beaten some of the backlog discussion to death, but maybe just one more for good measure. You mentioned that you were able to get a lot of product out the door in the first quarter. Wasn't really a lot of bottlenecks on your side. But a lot of the commentary about backlog seems kind of second half focused. Is there a point at which lead times sort of temper the order intake that folks say, hey, I'm not going to get this for a while, so I'm going to hold off and see what life is like? Or is it the inverse? Because it just seems like there's an awful lot of backlog pretty early in the year.

It depends on the business at the end of the day and the market structure. We tend to compete in some pretty concentrated market structures where unless there's a disparity between us and an individual competitor, that's what we're competing with. I think it remains to be seen whether the distribution demand begins to – that rate of increase slows down because if it's not liquidating – it's not liquidating out of distribution inventory at the same pace that it's coming in, then, obviously, it's going to slow down. It's a bit too early to tell, quite frankly. So, the long lead time items where markets are concentrated, I don't think it's going to have a negative impact on the short cycle side. What we're trying to do on the short cycle side is forcefully build the backlog because generally speaking, the bigger backlog that we are, the more efficient we are as producers, but that is going to be tied up on the competitive environment and product availability and everything else. So we'll see.

Thank you. That concludes our question-and-answer period and Dover's first quarter 2021 earnings conference call. You may now disconnect your lines at this time and have a wonderful day.